GlassScriptPhysician profile
Peter Alfio Rossi
NPI 1598757072
$11,226.21
in general payments reported to CMS, 2019-2025
43 companies · $1,381 in 2025
The $1,381 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $728 · 2020: $2,383 · 2021: $1,441 · 2022: $1,734 · 2023: $2,022 · 2024: $1,538 · 2025: $1,381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,938 · Education: $3.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,937.61 |
| Education | $3.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $1,600.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $1,210.28 | 2019-2024 | Xarelto |
| Pfizer INC. | $752.44 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $698.95 | 2019-2025 | |
| Amarin Pharma, INC. | $540.50 | 2019-2021 | |
| Abbott Laboratories | $521.05 | 2021-2025 | Navitor, Coroflow |
| Boehringer Ingelheim Pharmaceuticals, INC. | $475.78 | 2019-2025 | Jardiance |
| Amgen INC. | $442.85 | 2019-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $422.53 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $389.95 | 2020-2025 | Lifevest |
| Medtronic, INC. | $372.43 | 2021-2025 | Corevalve Evolut R, Reveal Linq, Affera Mapping System |
| Esperion Therapeutics, INC. | $348.34 | 2020-2025 | Nexletol, Nexlizet |
| Edwards Lifesciences Corporation | $315.66 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Zoll Circulation INC | $315.49 | 2021-2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
| Astrazeneca Pharmaceuticals LP | $314.24 | 2019-2023 | Farxiga |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $284.71 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $271.44 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cagent Vascular INC | $231.57 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $220.95 | 2019-2024 | Eliquis, Camzyos |
| Penumbra, INC. | $213.18 | 2020-2025 | Indigo System, Penumbra System |
| Lexicon Pharmaceuticals, INC. | $180.84 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $168.34 | 2022-2025 | Verquvo |
| Angiodynamics, INC. | $131.58 | 2023 | Auryon Laser System 100-120 Vac |
| Abiomed | $122.77 | 2020-2025 | |
| Scpharmaceuticals INC. | $89.31 | 2024-2025 | |
| Irhythm Technologies, INC. | $88.38 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $66.87 | 2022-2025 | Lm Undivided |
| Boston Scientific Corporation | $52.09 | 2019-2023 | Watchman Flx |
| Sanofi-Aventis U.S. LLC | $51.72 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $46.52 | 2023-2024 | Evkeeza |
| Medtronic Vascular, INC. | $39.01 | 2019 | |
| Tersera Therapeutics LLC | $33.68 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $28.33 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $27.29 | 2024 | Assure Wcd |
| Avinger INC. | $23.86 | 2022 | |
| Cardiovascular Systems INC. | $23.64 | 2019-2023 | Diamondback Coronary |
| Cardiva Medical, INC. | $19.95 | 2025 | Optowire |
| Impulse Dynamics (USA) INC. | $18.52 | 2023 | Optimizer |
| Kowa Pharmaceuticals America, INC. | $16.67 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $14.50 | 2020 | |
| Novo Nordisk INC | $14.10 | 2024 | Ozempic |
| Glaxosmithkline, LLC. | $13.87 | 2025 | Arexvy, Shingrix |
| Medicomp INC | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Rossi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.